Opinion|Videos|January 19, 2026

Final Thoughts on Improving Access and Care

Panelists discuss how collaboration, innovation, and stigma reduction are key to transforming schizophrenia care.

Panelists discuss how advancing schizophrenia care requires alignment among clinicians, policymakers, and industry to ensure consistent access to innovation.

Panelists discuss how integrating novel treatments with psychosocial support can improve adherence and empower patients toward recovery.

Panelists discuss how sustained efforts to reduce stigma and expand early intervention programs remain vital to achieving equitable, compassionate care.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo